Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ТИРАПАЗАМИН<.>)
Общее количество найденных документов : 38
Показаны документы с 1 по 20
 1-20    21-38 
1.
Еженедельный цисплатин+облучение по сравнению с цисплатином+тирапазамин+облучение при раке шейки матки, ограниченном малым тазом (IB2, IIA, IIB, IIIB и IVA стадии): рандомизированное исследование III фазы Gynecologic Oncology Group Study // J. Clin. Oncol. Рус. изд.. -Москва, 2014. Т. 8, N 2.-С.125

2.
Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148

3.
Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148

4.
Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148

5.
Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8

6.
Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8

7.
Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8

8.
A mass spectrometry study of tirapazamine and its metabolites: Insights into the mechanism of metabolic transformations and the characterization of reaction intermediates // J. Amer. Soc. Mass Spectrom., 2003. Vol. 14, N 8.-С.881-892

9.
Hypoxia-targeting agent in phase III lung Ca // Oncol. News Int., 2002. Vol. 11, N 1.-С.35

10.
Hypoxia-targeting agent in phase III lung Ca // Oncol. News Int., 2002. Vol. 11, N 1.-С.35

11.
Delahoussaye Yvette M. Metabolism of tirapazamine by multiple reductases in the nucleus // Biochem. Pharmacol., 2001. Vol. 62, N 9.-С.1201-1209

12.
Delahoussaye Yvette M. Metabolism of tirapazamine by multiple reductases in the nucleus // Biochem. Pharmacol., 2001. Vol. 62, N 9.-С.1201-1209

13.
Patterson L.H. Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidizing free-radicals under anaerobic conditions // Biochem. Pharmacol., 2000. Vol. 60, N 12.-С.1933-1935

14.
Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents // Cancer Res., 1999. Vol. 59, N 8.-С.1929-1934

15.
Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents // Cancer Res., 1999. Vol. 59, N 8.-С.1929-1934

16.
Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: The drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions // Biochemistry, 1999. Vol. 38, N 43.-С.14248-14255

17.
Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: The drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions // Biochemistry, 1999. Vol. 38, N 43.-С.14248-14255

18.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation // Radiat. Oncol. Invest., 1999. Vol. 7, N 3.-С.163-169

19.
Yuan Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma // Radiat. Oncol. Invest., 1999. Vol. 7, N 4.-С.218 -230

20.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation // Radiat. Oncol. Invest., 1999. Vol. 7, N 3.-С.163-169

 1-20    21-38 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)